ADENOSINE and DYSPNOEA

Overview

DYSPNOEA is the #6 most commonly reported adverse reaction for ADENOSINE, manufactured by Dalim Tissen. There are 74 FDA adverse event reports linking ADENOSINE to DYSPNOEA. This represents approximately 2.3% of all 3,219 adverse event reports for this drug.

Patients taking ADENOSINE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for ADENOSINE, but still significant enough to appear in the safety profile.

Other Side Effects of ADENOSINE

In addition to dyspnoea, the following adverse reactions have been reported for ADENOSINE:

• DRUG INEFFECTIVE — 327 reports
• OFF LABEL USE — 98 reports
• SUPRAVENTRICULAR TACHYCARDIA — 94 reports
• HYPOTENSION — 86 reports
• CARDIAC ARREST — 78 reports
• PAIN — 67 reports
• ATRIAL FIBRILLATION — 64 reports
• BRADYCARDIA — 63 reports
• TACHYCARDIA — 61 reports
• ANXIETY — 55 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does ADENOSINE cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 74 FDA reports for ADENOSINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with ADENOSINE?

DYSPNOEA accounts for approximately 2.3% of all adverse event reports for ADENOSINE, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking ADENOSINE?

If you experience dyspnoea while taking ADENOSINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages